CONTACT: Jeanan Yasiri Moe, Director of Strategic Communications [email protected] | 608.960.9892 $100K fund to accelerate solutions in development at UW-Madison MADISON, Wis. – The Wisconsin Alumni Research Foundation announced it…
Tune in to explore musical harmony and breakdown at SoundWaves webinar
CONTACT: Jeanan Yasiri Moe, Director of Strategic Communications [email protected] | 608.960.9892 First-ever virtual session of the live music + science program MADISON, Wis. – Join UW-Madison musicians and experts from…
Crossroads of Ideas program launches three-part COVID-19 series
CONTACT: Jeanan Yasiri Moe, Director of Strategic Communications [email protected] | 608.960.9892 MADISON, Wis. – From designing the ‘Badger shield’ to protect medical staff to combatting misinformation, how are UW-Madison researchers…
UW-Madison, FluGen, Bharat Biotech to develop CoroFlu, a coronavirus vaccine
CONTACT: UW-Madison: To contact Yoshihiro Kawaoka or Gabriele Neumann, please email Eric Hamilton at [email protected] or call (913) 424-8331. FluGen: Paul Radspinner, (608) 442-6561, [email protected] Bharat Biotech: Sheela Panicker, +91…
From lab to bedside, the Wisconsin Idea is all for the good of the patients
As doctors and leaders of health care systems, we are in business for only one reason — the patients and communities we serve. The Wisconsin Idea to us is the…
gBETA Madison announces spring 2020 companies
CONTACT: Jenni Le, gener8tor [email protected] | 309.431.0852 MADISON, WISCONSIN – Nationally ranked startup accelerator gener8tor has announced the participants in its gBETA Madison spring 2020 cohort, sponsored by the Wisconsin…
COVID-19: Tips and Resources for Entrepreneurs
Last week WARF and UW-Madison hosted a first-ever virtual summit to address what small businesses and entrepreneurs need to know, right now, about the COVID-19 pandemic. Experts from campus and…
WARF Therapeutics spring proposal deadline
Spring WARF Therapeutics (WT) Program Proposal Deadline: April 15 If you are a researcher working on a novel biological target, WARF Therapeutics may be able to help advance your work…